Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.73 |
| ▸ | GAA | P10253 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.72 |
| ▸ | ACHE | P22303 | 5/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.67 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.67 |
| ▸ | BCHE | P06276 | 4/20 | 0.60 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10061487 | 0.92 | HTT (0.67) | HTTGAAKMT2AMAPTACHE | |
| SCHEMBL9749208 | 0.89 | HTT (0.64) | HTTGAAKMT2AMAPTACHE | |
| SCHEMBL9208663 | 0.87 | HTT (0.74) | HTTGAAMAPTACHEBCHE | |
| SCHEMBL8473136 | 0.86 | HTT (0.69) | HTTGAAMAPTACHEHDAC6 | |
| SCHEMBL8472225 | 0.85 | HTT (0.71) | HTTGAAMAPTACHEBCHE | |
| SCHEMBL9747579 | 0.83 | BCHE (0.83) | HTTGAAKMT2AMAPTACHE | |
| SCHEMBL8474173 | 0.83 | BCHE (0.66) | HTTGAAMAPTACHEBCHE | |
| SCHEMBL9748781 | 0.82 | KDM4E (0.68) | HTTGAAKMT2AMAPTACHE | |
| SCHEMBL9382159 | 0.82 | KDM4E (0.65) | HTTGAAKMT2AMAPTACHE | |
| SCHEMBL9387187 | 0.81 | KDM4E (0.69) | HTTGAAKMT2AMAPTACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5861411-A | TREATING DISTURBANCES OF MEMORY SUCH AS SENILE DEMENTIA AND ALZHEIMER'S DISEASE | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-01-19 | — | — | US | disclosed |
| US-5536728-A | TREATMENT OF SENILE DEMENTIA AND ALZHEIMER'S DISEASE | MITSUBISHI CHEMICAL CORPORATION (JP) | 1996-07-16 | — | — | US | disclosed |
| EP-0427636-B1 | 4-Acylaminopyridine derivatives | MITSUBISHI CHEM CORP (JP) | 1996-05-29 | — | — | EP | disclosed |
| US-5397785-A | Activators of cholinergic neurons to treat memory disorders such as senile dementia and Alzheimer's disease | MITSUBISHI KASEI CORPORATION (JP) | 1995-03-14 | — | — | US | disclosed |
| EP-0319429-B1 | 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient | MITSUBISHI CHEM IND (JP) | 1994-04-27 | — | — | EP | disclosed |
| US-5175172-A | Administering amino-1,2,3,4-tetrahydroacridine and derivatives for elevation of T4 lymphocytes level in patients | DIETLIN FRANCOIS (FR) | 1992-12-29 | — | — | US | disclosed |
| EP-0427636-A2 | 4-Acylaminopyridine derivatives | Mitsubishi Chemical Corporation (JP) | 1991-05-15 | — | — | EP | disclosed |
| US-4985430-A | ALZHEIMER*S DISEASE | MITSUBISHI KASEI CORPORATION (JP) | 1991-01-15 | — | — | US | disclosed |
| EP-0319429-A2 | 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient | MITSUBISHI KASEI CORPORATION (JP) | 1989-06-07 | — | — | EP | disclosed |